Evidence suggesting that this year's flu vaccine missed the mark has caused the CDC to turn to other treatment strategies. This season's influenza virus strain is causing increasing hospitalizations and further complications. More concerning is the fact that approximately two-thirds of the H3N2 ...
Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug Administration says. Oct 17, 2024 0 1 Health What you need to know about cold and flu season As the fall months settle in, Canadians are being urged to take pre...
“For the upcoming Northern Hemisphere 2024-25 flu season, we will follow VRBPAC’s recommendation and will distribute [trivalent vaccine] in the United States,” a Sanofi spokesperson said in an email after the meeting concluded. “For the European region, we … anticipate the move to [trival...
VACCINE safetyThere is a critical need to understand vaccine decision-making in high-risk groups. This study explored flu vaccine acceptance among Jordanian parents of diabetic children. Employing a cross-sectional approach, 405 parents from multiple healthcare centers across Jordan...
The Food and Drug Administration has approved a "self-administered" influenza vaccine that could be available by next year's flu season. Dr. Roy Gulick, an infectious disease specialist at New York-Presbyterian Hospital, joins CBS News wit
Vaccination: annual flu vaccine recommended for over 65s, children, healthcare workers, and high-risk groups. Introduction Influenza is a commonviral infectionof the upper and lower respiratory tract caused by the influenza family of viruses. It is an endemic infection which most commonly occurs du...
thinking that they did not have this deadly flu. Others who caught it were sometimes more susceptible to developing complications such as pneumonia. The death toll would have been far worse, however, if scientists were not so speedy in developing and implementing a vaccine, which contained the ...
The single case occurred in a Phase 2 trial being conducted outside of the U.S. in a patient who was given the vaccine in January 2023. The trial was completed in July of that year and the participant reported the serious adverse event in September of 20...
“We are committed to developing vaccines that will reduce the burden of respiratory diseases and believe that combination vaccines are the most efficient way to do this,” Annaliesa Anderson, senior vice president and head, vaccine research and development at Pfizer, said in a prepared statement...
During the initialization period, only TIV is used as vaccine. During the evaluation period, each single simulation is run as a “TIV” and as a “QIV scenario”: (1) In order to keep the two scenarios closely matched, they use exactly the same contact network and demographic composition ...